The Lightning-Link range from Innova Biosciences enables scientists to develop antibody research tools within their own laboratories.
The Lightning-Link range has 43 individual signal labels, including enzymes, fluorescent proteins and dyes that span a variety of applications (WB, IH, FACS, ELISA, and FRET), colours and emission ranges.
Scientists are shifting away from studying single proteins to multi-component research for instance RNA splicing and transcription factories.
However, progress within the life science community has been protracted by the lack of commercially relevant antibodies that are directly labelled.
Conventional indirect methods (secondary antibody detection) have failed to evolve to meet this emerging demand and often, such techniques are difficult to optimise when analysing multi-component complexes in experiments such as western-blotting, immunofluorescence, immunohistochemistry and FACS.
The solution to these problems is via direct labelling of the primary antibody using conjugation.
However, in the past conjugation specialists were required for a successful outcome, development times varied between one to three days and multi-step approaches were needed for instance desalting.
Furthermore, normal conjugation technologies require bulk volumes of mg; researchers may only require ug of labelled antibody.
Recognising this emerging demand, Innova Biosciences has developed the Lightning-Link kit, which enables the end user to generate primary labelled antibody conjugates with a hands-on time of 30 seconds in a one-step format.
Additional features include scalability (ug to mg) and 100 per cent antibody recovery.
